ArticleGenes and immunity2025

GXYLT2: an emerging therapeutic target and predictive biomarker for anti-PD-1 efficacy in clear cell renal cell carcinoma.

Tuanjie Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.